GENEVA, May 27 -- PFIZER INC. (66 Hudson Boulevard EastNew York, New York 10001-2192) filed a patent application (PCT/IB2024/061303) for "SYNTHESIS OF 1,5-ANHYDRO-3-({5-CHLORO-4-[4-FLUORO-2-(2-HYDROXYPROPAN-2-YL)-1-(PROPAN-2-YL)-1H-BENZIMIDAZOL-6-YL]PYRIMIDIN-2-YL}AMINO)-2,3-DIDEOXY-D-THREO-PENTITOL" on Nov 14, 2024. With publication no. WO/2025/104624, the details related to the patent application was published on May 22, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ALEXANDER, Katy Louise (c/o Pfizer R&D UK LimitedRamsgate RoadSandwich Kent CT13 9NJ), ANSARI, Zarrin Fazal Khadija (c/o Ph...